Veterinary Infectious Disease Diagnostics Market, by Product Type and Application : Global Opportunity Analysis and Industry Forecast, 2019–2026

Veterinary Infectious Disease Diagnostics Market, by Product Type and Application : Global Opportunity Analysis and Industry Forecast, 2019–2026

  • March 2020 •
  • 206 pages •
  • Report ID: 5897567 •
  • Format: PDF
Veterinary Infectious Disease Diagnostics Market, by Product Type (Immunodiagnostics, Molecular Diagnostics, and Others) and Application (Dogs, Cats, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026

The global veterinary infectious disease diagnostics market was valued at $1,271 million in 2018, and is expected to reach $2,404 million by 2026, registering a CAGR of 8.3% from 2019 to 2026.
There are various types of infectious diseases, which affect companion animals. Furthermore, these diseases are fatal and can also lead to serious complications, if timely treatment is not provided. For instance, canine distemper is a common viral disease in dogs, which if left untreated lead to complications such as degeneration of the nervous system. Moreover, there are bacterial, parasitic and other type of infectious diseases as well that affect companion animals. The products used in procedures conducted to test the presence of infectious diseases in animals are known as veterinary infectious disease diagnostics. Moreover, there are different types of veterinary infectious disease diagnostics available in the market such as immunodiagnostics and molecular diagnostics. These are generally used to diagnose infectious diseases in animals such as cats and dogs.
Rise in ownership of companion animals and surge in animal health expenditure are the major factors that boost the veterinary infectious disease diagnostics growth of the global veterinary infectious disease diagnostics market. In addition, increase in prevalence of various infectious diseases among companion animals significantly drives the growth of the veterinary infectious disease diagnostics market. However, lack of awareness related to the use of veterinary infectious disease diagnostics in underdeveloped countries restricts the growth of the market. On the contrary, surge in awareness related to animal healthcare across the globe is expected to offer remunerative opportunities for market expansion during the forecast period.
The global veterinary infectious disease diagnostics market size is studied on the basis of product type, application, and region. On the basis of product type, it is segmented into immunodiagnostics, molecular diagnostics, and others. By application, it is classified into dogs, cats, and others. By region, it is analyzed across North America (the U.S, Canada, and Mexico) and Europe (Germany, France, Italy, the UK and rest of Europe), Asia-Pacific (Japan, China, India, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA). .

KEY BENEFITS FOR STAKEHOLDERS
• This report entails a detailed quantitative analysis along with the current global veterinary infectious disease diagnostics market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment.
• The market size and estimations are based on a comprehensive analysis of key developments in the industry.
• A qualitative analysis based on innovative products facilitates strategic business planning.
• The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

Key Market Segments
• By Product Type
o Immunodiagnostics
o Molecular Diagnostics
o Others
• By Application
o Dog
o Cat
o Others
• By Region
o North America
o U.S.
o Canada
o Mexico
o Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
o Asia-Pacific
o Japan
o China
o Australia
o Rest of Asia-Pacific
o LAMEA
o Brazil
o Saudi Arabia
o South Africa
Rest of LAMEA
List of key players profiled in the report:
• Biomérieux SA
• HESKA Corporation
• IDEXX Laboratories, Inc.
• ID.Vet, Neogen Corporation
• Qiagen N.V.
• Randox Laboratories Ltd
• Thermo Fisher Scientific Inc
• Virbac,
• Zoetis

LIST OF OTHER PLAYERS IN THE VALUE CHAIN(These players are not profiled in the report. The same will be included on request)
• Eurofins Technologies
• AusDiagnostics Pty, Ltd.